UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | G | H | J | K | L | M | P | R | S | T | W | Y | Z
Number of items: 63.


Adams, VC; Hunt, JR; Rosa Brunet, L; Rook, GAW; (2002) Effect of Mycobacterium vaccae on ICOS expression in a murine model. Presented at: UNSPECIFIED.

Ahn, JW; Powell, KL; Kellam, P; Alba, MM; (2002) Gammaherpesvirus lytic gene expression as characterised by DNA array. Journal of Virology , 76 (12) pp. 6244-6256.

Anand, A; Dean, GS; Quereshi, K; Isenberg, DA; Lydyard, PM; (2002) Characterisation of CD3+, CD4-, CD8- (double negative) T cells in patients with systemic lupus erythematosus (SLE): activation markers. Lupus , 11 pp. 493-500.

Andersson, J; Kinloch, S; Sonnerborg, A; Nilsson, J; Fehniger, TE; Spetz, AL; Behbahani, H; (2002) Low levels of perforin in CD8+ T lymphocytes in lymphoid tissue during acute human immunodeficiency virus type 1 infection. The Journal of Infectious Diseases , 185 pp. 1355-1358.


Boshoff, C; Weiss, RA; (2002) AIDS-related malignancies. Nature Reviews Cancer , 2 pp. 373-382.


Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: twelve month use of linezolid for Gram-positive infections in ICU. Presented at: European Congress of Chemotherapy.

Cepeda, JA; Hayman, SJ; Kibbler, C; Wilson, APR; (2002) In vitro susceptibility of Gram-positive cocci to linezolid and teicoplanin: use of linezolid for Gram-positive infections in ICU. Presented at: UNSPECIFIED.

Cepeda, JA; Whitehouse, T; Cooper, B; Hails, J; Hayman, SJ; Jones, K; Kwaku, F; (2002) Linezolid versus teicoplanin in the treatment of Gram positive infections in the critically ill: a randomized, double-blind, multicentre study. Presented at: 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; Shaw, S; (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. Presented at: UNSPECIFIED.

Cepeda, JA; Whitehouse, T; Tobin, C; Zhang, J; MacGowan, A; Kibbler, C; Shaw, S; (2002) The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill. Presented at: European Congress of Chemotherapy.

Cepeda, JA; Whitehouse, T; Wilson, APR; Singer, M; Bellingan, G; Kibbler, C; Shaw, S; (2002) MRSA clearance during treatment with linezolid. Presented at: European Congress of Chemotherapy.


Davies, K; Woo, P; (2002) Immunisation in rheumatic diseases of childhood: an audit of the clinical practice of BPRG members and a review of the evidence. Rheumatology , 41 pp. 937-941.


Garson, J; Aggarwal, A; Sarkar, S; (2002) Birds as surrogates for biodiversity: an analysis of a data set from southern Quebec. J.Biosci. , 27 (4 Supp) pp. 347-360.

Gillespie, SH; Billington, OJ; Breathnach, A; McHugh, TD; (2002) Multiple drug resistant tuberculosis: evidence for changing fitness on passage through human hosts. Microbial Drug Resistance , 8 pp. 1-7.

Griffiths, PD; (2002) Benefits of bioterrorism. Reviews In Medical Virology , 12 (3) pp. 131-132.

Griffiths, PD; (2002) Interactions between viral and human genes. Reviews In Medical Virology , 12 (4) pp. 197-199.

Griffiths, PD; (2002) Preparing to treat prions. Reviews In Medical Virology , 12 (1) pp. 1-3.


Hopkins, S; Hennessy, M; Lyons, F; Mulachy, F; Bergin, C; (2002) Treatment of chronic Hepatitis C with pegylated interferon and ribavirin in HIV co-infected patients. In: HEPATOLOGY. (pp. 231A - 231A).

Huggett, JF; Mustafa, A; O'Neil, L; Mason, DJ; (2002) Does osteogenesis differentially regulate GLAST-1 and GLAST-1a? Presented at: UNSPECIFIED.



Jolles, S; Downey, J; Buxton, RS; (2002) DNA microarrays. CPD Bulletin Immunology and Allergy , 2 (3) pp. 84-88.


Kellam, P; Alb, MM; (2002) Virus bioinformatics: databases and recent applications. Applied Bioinformatics , 1 (1) pp. 37-42.

Kellam, P; Mar Alba, M; (2002) Databases and recent applications. Applied Bioinformatics , 1 (1) pp. 37-42.

Kellam, P; Xiaohui, L; Martin, NJ; Orengo, CA; Swift, S; Tucker, A; (2002) A framework for modelling virus gene expression data. Intelligent Data Analysis , 5 pp. 1-13.

Kinloch, SA; B, ; (2002) HIV-1 therapeutic vaccines. Journal of INfection , 44 pp. 152-159.


Lilley, CE; Coffin, RS; (2002) Herpes simplex virus vectors. In: Machida, CE, (ed.) Virus vectors for gene therapy: methods and protocols. (pp. 33-50). Humana Press: New York.


Maini, MK; Bertoletti, A; (2002) Cytokines in viral hepatitis. In: Kobt, M and Calandra, T, (eds.) Cytokines and chemokines in infectious diseases. (pp. 355-375). Humana Press

Mason, DJ; Huggett, JF; (2002) Glutamate transporters in bone. Journal of Musculoskeletal and Neuronal Interactions , 2 (5) pp. 406-414.

Messina, CG; Reeves, EP; Roes, J; Segal, AW; (2002) Catalase negative Staphylococcus aureus retain virulence in mouse model of chronic granulomatous disease. FEBS Letters , 518 (1-3) pp. 107-110.

Mitchison, NA; Roes, JT; (2002) Patterned variation in murine MHC promoters. Proceedings of the National Academy of Sciences of the United States of America , 99 (16) pp. 10561-10566. 10.1073/pnas.152329999.


Palmer, JA; Coffin, RS; (2002) Target validation in the nervous system using herpes simplex viral vectors. European Pharmaceutical Review , Winter pp. 64-70.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Conditioning regimen may influence outcome of ABO incompatible non-myeloablative haemtopoietic allogeneic stem cell transplantation. Blood , 99 pp. 4642-4644.

Perrin, L; Cooper, DA; Hoen, B; Kinloch, S; Phillips, A; Tsoukas, C; Andersson, J; (2002) Therapeutic vaccination in primary HIV infection, the Quest trial. Vaccine , 20 (15) pp. 2004-2006. 10.1016/S0264-410X(02)00087-7.

Pers, JO; Berthou, C; Porakishvili, N; Burjanadze, M; Le Calvez, G; Abgrall, JF; Lydyard, PM; (2002) CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia , 16 (1) pp. 44-52.

Pers, JO; Jamin, C; Lydyard, PM; Charriere, J; Youinou, P; (2002) The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Immunogenetics , 54 (3) pp. 208-211.

Porakishvili, N; Jewell, AP; Kwee, Y; Akbar, A; Lydyard, PM; (2002) CD4+PF+ T cells with regulatory phenotype in B cell chronic lymphocytic leukaemia (B-CLL). In: BLOOD. (pp. 356B - 356B).


Rook, GA; Lightman, SL; Heijnen, CJ; (2002) Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends in Immunology , 23 (1) pp. 18-22.

Rook, GAW; (2002) Immunoregulation: the hygiene hypothesis and the brain. In: Immunology. (pp. 40 - 40).

Rook, GAW; Rosa Brunet, L; Hunt, J; (2002) Multiple consequences of the changing educational input to our immune systems. In: Heidt, PJ and Midtvedt, T and Rusch, V and van der Waaij, D, (eds.) Probiotics: Bacteria and Bacterial Fragments as Immunomodulatory Agents. (pp. 35-53). Institut f+r Integrative Biologie GmbH: Herborn-Dill, Germany.


Sadiq, ST; Taylor, S; Kaye, S; Bennett, J; Johnstone, R; Byrne, P; Copas, AJ; (2002) The effects of antirectroviral therapy on HIV-1 RNA loads in seminal plasma in HIV positive patients with and without urethritis. AIDS , 16 (2) pp. 219-255. 10.1097/00002030-200201250-00011.

Schofield, JN; Stephens, JW; Hurel, SJ; Bell, KM; deSouza, JB; Rademacher, TW; (2002) Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type 1 diabetic patients and streptozotocin diabetic rats. Molecular Genetics and Metabolism , 2 (154) 161-.

Simmonds, P; Kurtz, J; Tedder, RS; (2002) The UK blood transfusion service: over a (patent) barrel? The Lancet , 359 (9319) pp. 1713-1714.

Stringer, C; Chiodini, J; Zuckerman, JN; (2002) Continuing Professional Development in Travel Medicine. The Nursing Standard , 16 (39) pp. 49-54.


Temperton, NJ; (2002) DNA vaccines against cytomegalovirus: current progress. International Journal of Antimicrobial Agents , 19 (3) pp. 169-172.

Thomas, SK; Lilley, CE; Latchman, DS; Coffin, RS; (2002) A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J VIROL , 76 (8) 4056 - 4067. 10.1128/JVI.76.8.4056-4067.2002.

Thomson, W; Barrett, JH; Donn, R; Pepper, L; Kennedy, LJ; Ollier, WE; Silman, AJ; (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) , 41 (10) pp. 1183-1189.


Walker, SJ; Pizzato, M; Takeuchi, Y; Devereux, S; (2002) Heparin binds to murine leukaemia virus and inhibits Env-independent attachment and infection. Journal of Virology , 76 pp. 6909-6918.

Wedderburn, LR; Patel, A; Woo, P; (2002) Direct visualisation of the cytokine driven synovial T cell response in juvenile idiopathic arthritis. Presented at: UNSPECIFIED.

Weiss, RA; (2002) HIV receptors and cellular tropism. IUBMB LIFE , 53 (4-5) 201 - 205. 10.1080/15216540290098927.

Weiss, RA; (2002) Reflections on the origin of human immunodeficiency viruses. AIDS and Hepatitis Digest , 87 pp. 2-4.

Weiss, RA; (2002) Xenotransplantation: promise and problems. In: Brooks, G, (ed.) Gene Therapy: the use of DNA as a drug. (pp. 295-312). Pharmaceutical Press

Whitehouse, T; Cepeda, J; Cooper, B; Hails, J; Jones, K; Kwaku, F; Taylor, L; (2002) Treatment of bacteraemia and LRTI with linezolid in the critically ill patient: a randomized double-blind comparison against teicoplanin. Presented at: 15th Annual Congress of the European Society of Intensive Care Medicine..

Wilkinson, J; Cope, A; Gill, J; Bourboulia, D; Hayes, P; Imami, N; Kubo, T; (2002) Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretr. Journal of Virology , 76 (6) pp. 2634-2640.


Yang, TH; Lovatt, M; Merkenschlager, M; Stauss, HJ; (2002) Comparison of the freqency of peptide-specific CTL restricted by self and allo-MHC following in vitro T cell priming. International Immunology , 14 (11) pp. 1283-1290.

Youinou, P; Lydyard, PM; Mageed, RA; (2002) B cells underpin lupus immuno-pathology. Lupus , 11 (1) pp. 1-3.


Zuckerman, J; (2002) Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 pp. 260-264.

Zuckerman, JN; (2002) Clinical Review: Recent Advances in Travel Medicine. BMJ (Clinical Research Ed.) , 325 pp. 260-264.

Zuckerman, JN; (2002) Health and illness among airline passengers. In: Bor, R, (ed.) Passenger Behaviour. (pp. 232-246). Ashgate Publishing

Zuckerman, JN; (2002) Travel health advice for travellers with immunosuppressive disorders. In: Howarth-Wilson, J, (ed.) Bugs, Bowels & Bites. Cadogan Guides

Zuckerman, JN; (2002) A guide to the medical student elective abroad. In: Ryan, J and Greaves, I and Mahoney, P and Bowyer, G, (eds.) Handbook of Medicine in Hostile Environments. (pp. 131-141). Springer-Verlag London

Zuckerman, JN; (2002) International Travel and Health 2002. In: World, HO, (ed.) International Travel and Health 2002. (pp. 1-210). World Health Organisation

Zuckerman, JN; Zuckerman, AJ; (2002) Viral hepatitis. In: Dawood, R, (ed.) Travellers' Health. (pp. 54-62). Oxford University Press

Zuckerman, JN; Zuckerman, AJ; (2002) Molecular Epidemiology of Hepatitis B virus. In: Leitner, T, (ed.) The Molecualr Epidemiology of Human Viruses. (pp. 401-419). Kluwer Academic Publishers

This list was generated on Sun Nov 27 06:13:27 2016 GMT.